Several specialized companies worldwide focus on the synthesis of complex pharmaceutical APIs, notably Abacavir Sulfate sulfate, Abarelix, and Abiraterone Mesylate. These compounds present significant hurdles in process development due to their molecular complexity. The suppliers of these APIs often employ sophisticated technologies and adhere to s